Insights

Product Portfolio Diversification Criticare Systems offers a comprehensive range of patient monitoring devices suitable for anesthesia, critical care, respiratory care, transport, and outpatient care. This diverse product portfolio presents sales opportunities across various healthcare facilities and professionals.

Acquisition Synergies The acquisition of Unetixs Vascular has strengthened Criticare's portfolio by adding physiologic vascular detection and diagnostic equipment. Leveraging this expanded product line, the sales team can target vascular surgeons, cardiologists, podiatrists, and other medical professionals seeking high-quality noninvasive peripheral vascular testing systems.

Addressing Growing Healthcare Trends With a focus on patient safety and monitoring needs in critical care settings, Criticare's solutions align well with the healthcare industry's emphasis on quality care delivery. Sales representatives can leverage this alignment to position the company as a partner in addressing the increasing prevalence of peripheral arterial disease (PAD) and other vascular conditions globally.

Competitive Positioning While Criticare Systems competes with established players like GE Healthcare and Medtronic, its emphasis on cost-containment features and innovative product offerings provides a competitive edge. Sales teams can highlight the affordability and productivity of Criticare's systems compared to competitors, attracting cost-conscious healthcare facilities.

Market Expansion Opportunities Given the international presence of Criticare Systems, there are sales expansion opportunities in emerging economies where the prevalence of vascular diseases is on the rise. Sales professionals can explore partnerships with healthcare providers in these regions to introduce Criticare's advanced monitoring systems and accessories, tapping into unmet market needs.

Criticare Systems Tech Stack

Media & News

Criticare Systems's Email Address Formats

Criticare Systems uses at least 1 format(s):
Criticare Systems Email FormatsExamplePercentage
First.Last@csiusa.comJohn.Doe@csiusa.com
86%
FLast@csiusa.comJDoe@csiusa.com
7%
FirstLast@csiusa.comJohnDoe@csiusa.com
5%
F.Last@csiusa.comJ.Doe@csiusa.com
2%

Frequently Asked Questions

What is Criticare Systems's stock symbol?

Minus sign iconPlus sign icon
Criticare Systems is a publicly traded company; the company's stock symbol is CMD1.

What is Criticare Systems's official website and social media links?

Minus sign iconPlus sign icon
Criticare Systems's official website is csiusa.com and has social profiles on LinkedIn.

How much revenue does Criticare Systems generate?

Minus sign iconPlus sign icon
As of September 2024, Criticare Systems's annual revenue reached $19M.

What is Criticare Systems's SIC code NAICS code?

Minus sign iconPlus sign icon
Criticare Systems's SIC code is 3845 - Electromedical and Electrotherapeutic Apparatus NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Criticare Systems have currently?

Minus sign iconPlus sign icon
As of September 2024, Criticare Systems has approximately employees across 5 continents, including North AmericaAsiaSouth America. Key team members include Chief Financial Officer: M. S.VP & GM: J. L.Founder And President And Chief Executive Officer: R. D.. Explore Criticare Systems's employee directory with LeadIQ.

What industry does Criticare Systems belong to?

Minus sign iconPlus sign icon
Criticare Systems operates in the Medical Equipment Manufacturing industry.

What is Criticare Systems's email format?

Minus sign iconPlus sign icon
Criticare Systems's email format typically follows the pattern of . Find more Criticare Systems email formats with LeadIQ.
Criticare Systems

Criticare Systems

Medical Equipment Manufacturing

Criticare Systems, Inc. (CSI) is an international medical device company headquartered in Waukesha, Wisconsin. CSI develops, markets, and distributes a wide range of patient monitoring devices that incorporate technological innovation and cost-containment features. The company's products address patient safety concerns and monitoring needs in anesthesia, critical care, respiratory care, transport, and outpatient care environments. Comprehensive customer support, economical rental ownership programs, prompt equipment service, and technical support programs make even its most advanced systems affordable and consistently productive. In the summer of 2010, Criticare Systems, Inc. acquired Rhode Island-based Unetixs Vascular, Inc., a company that specializes in manufacturing and distributing physiologic vascular detection and diagnostic equipment. For over 20 years, Unetixs has developed high-quality, noninvasive peripheral vascular testing systems for use in physician offices, vascular labs, hospitals, and mobile testing units, utilized by a wide range of medical professionals including vascular surgeons, cardiologists, and podiatrists. Unetixs’ dedication to the detection of peripheral arterial disease (PAD), a condition that is affecting a growing portion of the population in both the developed world and in emerging economies, as well as other vascular diseases compliments Criticare’s already strong portfolio of patient monitoring systems and accessories.

Section iconCompany Overview

Website
csiusa.com
SIC Code
3845 - Electromedical and Electrotherapeutic Apparatus
Stock Symbol
CMD1
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing

Section iconMedia & News

Section iconFunding & Financials

  • $10M$50M

    Criticare Systems's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Criticare Systems's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.